Amphastar Pharmaceuticals, Inc. (AMPH) Net margin 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) net profit margin by fiscal year — reported net income divided by reported revenue.
13.6%FY2025 · since FY2016: 3.8% → 13.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 13.6% | -8.2 pp |
| FY2024 | 21.8% | +0.4 pp |
| FY2023 | 21.3% | +3.0 pp |
| FY2022 | 18.3% | +4.1 pp |
| FY2021 | 14.2% | +13.8 pp |
| FY2020 | 0.4% | -14.8 pp |
| FY2019 | 15.2% | +17.1 pp |
| FY2018 | -1.9% | -3.5 pp |
| FY2017 | 1.5% | -2.3 pp |
| FY2016 | 3.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice